Home / Drugs / Dichlorphenamide

Dichlorphenamide

FDA Drug Profile — ORMALVI, Dichlorphenamide, Keveyis

Drug Details

Generic Name
Dichlorphenamide
Brand Names
ORMALVI, Dichlorphenamide, Keveyis
Application Number
ANDA215924
Sponsor
Aurobindo Pharma Limited
NDC Codes
7
Dosage Forms
POWDER, TABLET
Routes
ORAL
Active Ingredients
DICHLORPHENAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. Dichlorphenamide tablets are an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )